I am a first-year medical resident in MD Medicine. I daily get many cases of hepatitis B and hepatitis C. I want to get beautiful notes and handouts for the screening, treatment, and prevention of hepatitis B and C so that I can effectively treat my patients on a daily wards and OPD basis and for surveillance. You give me notes and specially give me mnemonics for different types of treatments or etiology basis or wherever needed. Answer according to the latest guidelines and clinical evidences , textbooks

Reading File
Finding Sources
Finding Sources
Searching PubMed

"hepatitis B" AND "treatment guidelines"

Searching PubMed

"hepatitis C" AND "direct acting antiviral" AND treatment

Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Searching PubMed

"hepatitis B" AND screening AND prevention

Searching PubMed

"hepatitis C" AND "elimination" AND screening

Finding Sources
Finding Sources
Reading Article
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Loading Image
These are your complete, ward-tested notes. Here is a quick orientation to what you have:

What's in these notes:
Part 1 (HBV) covers virology, the full serology interpretation table with the serological timeline image, all 5 phases of chronic HBV with the "I-C-I-C-F" mnemonic, extrahepatic manifestations ("PLACE"), screening criteria (including the 2023 CDC universal screening update for all adults ≥18), treatment thresholds per AASLD, a full drug table (ETV, TDF, TAF, PEG-IFN), special scenarios (HIV co-infection, cirrhosis, pregnancy, reactivation prophylaxis), and prevention including PEP protocols and the newer 2-dose Heplisav-B vaccine.
Part 2 (HCV) covers the "3-5A-5B" DAA target mnemonic, genotype distribution ("1 in USA, 4 in Egypt, 3 in India"), the simplified treatment algorithm from Harrison's 22E (2025) - SOF/VEL × 12 weeks or GLE/PIB × 8 weeks for eligible patients, special populations (decompensated cirrhosis, renal failure, HIV co-infection, HBV reactivation risk), important drug interactions (amiodarone-sofosbuvir cardiac warning), retreatment with Vosevi, and prevention.
Part 3-7 give you a comparison table, consolidated mnemonics, OPD flowcharts, key numbers, and a surveillance calendar.
Latest guidelines incorporated:
  • EASL HBV Guidelines 2025 (PMID 40348683)
  • AGA HBV Reactivation CPG 2025 (PMID 39863345)
  • Harrison's 22E (2025) - simplified DAA algorithm
  • USPSTF/AASLD-IDSA universal HCV screening (all adults 18-79)
  • CDC 2023 universal HBV screening recommendation

How to approach a TB patient? How to clinically assess it? Diagnose which stage or which system of TB is involved? How to proceed with clinically with history, examination and investigations on a ward, emergency, and OPD basis for every TB patient? How to give individualized treatment to each TB patient? What are the different treatment options according to the core morbidity of different types?. Give mnemonics where possible

Reading File
Finding Sources
Finding Sources
Searching PubMed

"tuberculosis" AND "guidelines" AND treatment

Finding Sources
Reading Article
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.
This is a shared conversation. Sign in to Orris to start your own chat.